Dr Lloyd Einsiedel – The Human T-Lymphotropic Virus type 1: a cause of morbidity and mortality in central Australia

Image - Dr Lloyd Einsiedel – The Human T-Lymphotropic Virus type 1: a cause of morbidity and mortality in central Australia

 

 
Infectious Diseases Physician, Alice Springs Hospital;
Associate Director of Research, Aboriginal Health, Baker IDI Heart and Diabetes Institute
 
 
About your speaker
Dr Lloyd Einsiedel is an infectious diseases physician who has provided a clinical service to central Australia for more than a decade. He has active research interests in Indigenous health with particular reference to interactions between the social determinants of health, health literacy and disease.
 
Abstract
Working with international collaborators at Imperial College, London, and the Institut Pasteur, Paris, Dr Lloyd Einsiedel has sought to understand the implications of infection with the Human T-Lymphotropic Virus type 1 (HTLV-1) among the Indigenous people of central Australia. This presentation will describe the epidemiology, clinical associations and outcomes of HTLV-1 infection in central Australia. In this setting, prevalence rates exceed 40% for adult residents of remote communities in which seroprevalence studies have been completed. The virus is associated with a rapidly fatal adult T-cell leukaemia, inflammatory diseases that affect a variety of organ systems including the lung and increased mortality in prospective studies.
Location
Berg Family Foundation Seminar Room Level 6, Wallace Wurth Building, UNSW Australia, Sydney
Cost
Free
Event date
Mon, 20/02/2017 -
1:00pm to 2:00pm
Contact for inquiries
Rata Joseph, +61 (2) 9385 0900 or rjoseph@kirby.unsw.edu.au